Russell Investments Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$130K Buy
5,038
+13
+0.3% +$336 ﹤0.01% 2758
2025
Q1
$51.3K Buy
5,025
+503
+11% +$5.13K ﹤0.01% 2904
2024
Q4
$63.1K Sell
4,522
-1,441
-24% -$20.1K ﹤0.01% 2774
2024
Q3
$116K Sell
5,963
-17
-0.3% -$331 ﹤0.01% 2619
2024
Q2
$111K Buy
5,980
+484
+9% +$9K ﹤0.01% 2608
2024
Q1
$77K Sell
5,496
-2,022
-27% -$28.3K ﹤0.01% 2607
2023
Q4
$63.7K Sell
7,518
-3,061
-29% -$25.9K ﹤0.01% 2614
2023
Q3
$94.5K Sell
10,579
-115
-1% -$1.03K ﹤0.01% 2634
2023
Q2
$92.3K Hold
10,694
﹤0.01% 2620
2023
Q1
$113K Sell
10,694
-179
-2% -$1.89K ﹤0.01% 2567
2022
Q4
$369K Buy
10,873
+5,334
+96% +$181K ﹤0.01% 2390
2022
Q3
$264K Buy
5,539
+5,307
+2,288% +$253K ﹤0.01% 2469
2022
Q2
$13K Sell
232
-582
-71% -$32.6K ﹤0.01% 2834
2022
Q1
$64K Sell
814
-141
-15% -$11.1K ﹤0.01% 2612
2021
Q4
$193K Sell
955
-321
-25% -$64.9K ﹤0.01% 2723
2021
Q3
$343K Sell
1,276
-92
-7% -$24.7K ﹤0.01% 2604
2021
Q2
$351K Sell
1,368
-681
-33% -$175K ﹤0.01% 2728
2021
Q1
$613K Sell
2,049
-925
-31% -$277K ﹤0.01% 2443
2020
Q4
$762K Sell
2,974
-83
-3% -$21.3K ﹤0.01% 2243
2020
Q3
$759K Sell
3,057
-321
-10% -$79.7K ﹤0.01% 2196
2020
Q2
$1.17M Buy
3,378
+3,306
+4,592% +$1.15M ﹤0.01% 1962
2020
Q1
$19K Buy
72
+51
+243% +$13.5K ﹤0.01% 2956
2019
Q4
$6K Sell
21
-239
-92% -$68.3K ﹤0.01% 3060
2019
Q3
$70K Hold
260
﹤0.01% 2892
2019
Q2
$136K Hold
260
﹤0.01% 2588
2019
Q1
$128K Buy
260
+22
+9% +$10.8K ﹤0.01% 2698
2018
Q4
$120K Sell
238
-97
-29% -$48.9K ﹤0.01% 2699
2018
Q3
$305K Sell
335
-2,861
-90% -$2.6M ﹤0.01% 2556
2018
Q2
$2.34M Sell
3,196
-1,367
-30% -$1M ﹤0.01% 1688
2018
Q1
$7.26M Sell
4,563
-3,065
-40% -$4.88M 0.01% 1152
2017
Q4
$6.92M Sell
7,628
-836
-10% -$759K 0.01% 1160
2017
Q3
$3.05M Sell
8,464
-350
-4% -$126K 0.01% 1539
2017
Q2
$2.59M Buy
8,814
+2,750
+45% +$807K ﹤0.01% 1587
2017
Q1
$2.14M Buy
6,064
+711
+13% +$250K ﹤0.01% 1726
2016
Q4
$979K Buy
+5,353
New +$979K ﹤0.01% 2180